Myrobalan Therapeutics

Medford, MA · Founded 2021 · Privately Held (backing)

Operator of a therapeutic biotechnology company intended for developing oral neurorestorative therapies aimed at reversing key pathologies underlying brain dysfunctions and central nervous system… Myrobalan Therapeutics is based in Medford, MA and was founded in 2021. It has raised $43 million.

Last price · $/share
—
Implied valuation
—
Total raised
$43.0M
Last round
—

Who backs Myrobalan Therapeutics?

9 investors
InvestorType
Johnson & Johnson Innovation - JLABSOther
Co-Win VenturesOther
Proxima Ventures (China)Venture capital
3E Bioventures CapitalVenture capital
AB Magnitude Ventures Group—
Cambridge Scientific Products—
Guanzi Capital—
National Multiple Sclerosis Society (NMSS)—
The ALS Association—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Myrobalan Therapeutics investors

9 investors are on record for Myrobalan Therapeutics, including Johnson & Johnson Innovation - JLABS, Co-Win Ventures, Proxima Ventures (China) and 3E Bioventures Capital.

Private Market View
More of Myrobalan Therapeutics with a free Private Market View account
  • ·Watch Myrobalan Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like Myrobalan Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View